Estudo Comparativo, Aleatorizado, em Dupla Ocultação, de Orlistat Versus Placebo, de Eficácia e Segurança, em Doentes Obesos com Hipercolesterolemia Ligeira a Moderada

INTRODUCTION: Obesity is a chronic disease and a serious health problem that leads to increased prevalence of diabetes, hypertension, dyslipidemia and gallbladder disease. OBJECTIVE: To evaluate the efficacy of orlistat for weight loss and improved lipid profile compared to placebo in obese patients...

Full description

Bibliographic Details
Main Author: Castro, JJ (author)
Other Authors: Dias, T (author), Chambel, P (author), Carvalheiro, M (author), Correia, LG (author), Guerreiro, L (author), Marques, O (author), Medina, JL (author), Nobre, E (author), Silva Nunes, J (author), Pereira, MC (author), Polónia, J (author), Portugal, J (author), Raimundo, A (author), Ruas, A (author), Marques da Silva, P (author), Vasconcelos, C (author), Lima Reis, J (author), Galvão Teles, A (author)
Format: article
Language:por
Published: 2011
Subjects:
Fármacos Anti-Obesidade
Hipercolesterolemia
Obesidade
Estudo Comparativo
Estudo Multicêntrico
Ensaio Randomizado Controlado
Triglicéridos
Orlistat
Colesterol
Online Access:http://hdl.handle.net/10400.17/239
Country:Portugal
Oai:oai:repositorio.chlc.min-saude.pt:10400.17/239

Internet

http://hdl.handle.net/10400.17/239

Similar Items